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E-mail address: Aziz_Sancar@med.unc.edu (A. SanMammalian cells possess a cell-autonomous molecular clock which controls the timing of many
biochemical reactions and hence the cellular response to environmental stimuli including genotoxic
stress. The clock consists of an autoregulatory transcription–translation feedback loop made up of
four genes/proteins, BMal1, Clock, Cryptochrome, and Period. The circadian clock has an intrinsic
period of about 24 h, and it dictates the rates of many biochemical reactions as a function of the
time of the day. Recently, it has become apparent that the circadian clock plays an important role
in determining the strengths of cellular responses to DNA damage including repair, checkpoints,
and apoptosis. These new insights are expected to guide development of novel mechanism-based
chemotherapeutic regimens.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The circadian clock and the DNA damage response are two glo-
bal regulatory mechanisms that control many aspects of cellular
physiology and adaptation to the environment at the cellular and
organismal level. The two regulatory systems can operate indepen-
dently of one another. However, under physiological conditions,
the two systems interface. As a consequence, a signal that primar-
ily affects one system, to varying degrees, ultimately affects the
other as well. In this review we will mainly focus on our current
understanding of the control of the DNA damage response by the
circadian clock. The DNA damage response includes DNA repair,
DNA damage checkpoints, apoptosis, and transcriptional repro-
gramming, and current evidence indicates that all these responses
are gated by the circadian clock (Fig. 1). In the following, the basic
molecular mechanism of the mammalian clock will be described
ﬁrst, followed by a survey of recent ﬁndings on the control of the
DNA damage response by the clock, and how these ﬁndings may
be used to develop new chemotherapy regimens. Finally, we dis-chemical Societies. Published by E
dback loop; CCG, clock-con-
violet; IR, ionizing radiation;
r, Period; Tim, Timeless; PIC,
AD, caspase activated DNase;
car).cuss the possible evolutionary link between the circadian clock
and the cellular response to DNA damage.
2. Molecular circadian clock
The circadian clock is the molecular system that confers daily
rhythmicity to physiologic functions [1–4]. The clock is cell-auton-
omous and self-sustaining; that is, it keeps time in the absence of
external input. However, in mammalian organisms the cell-auton-
omous clocks in the peripheral organs such as liver, heart, kidney,
and skin are synchronized with one another by neural and humoral
inputs from the ‘‘master clock” in the brain [1]. The master clock is
located in the suprachiasmatic nucleus (SCN) which is in the ante-
rior hypothalamus in two clusters of neurons above the optic chi-
asma. The basic molecular architecture of the SCN clock is the same
as those of the peripheral clocks; however, the SCN has the capabil-
ity of signaling to, and thus synchronizing, the peripheral clocks
with itself and with one another.
At the molecular level the clock is made up of four genes/pro-
teins: Clock, BMal1, Crys (Cryptochrome 1 and 2), and Pers (Period
1 and 2) which operate in the following manner to generate a tran-
scription-translation feedback loop (TTFL) (Fig. 2): Clock and
BMal1 are bHLH-PAS domain-containing transcriptional activators
which make a heterodimer that binds to the E-boxes (CACGTG) in
the promoters of the Cry and Per genes and activate their transcrip-
tion. The Cry and Per proteins, in turn, make heterodimers or high-
er order multimeric complexes which, after a time lag, enter thelsevier B.V. All rights reserved.
Fig. 1. Circadian gating of DNA damage responses. Major cellular response
pathways to DNA damage including DNA repair, DNA damage checkpoints,
apoptosis, and transcriptional reprogramming are gated by the circadian clock.
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BMal1 also controls the transcription of about 10% of the genes
in a given cell, causing rhythmic expression of these so-called
clock-controlled genes (CCG) [5]. In contrast to Crys and Pers, the
proteins encoded by CCGs do not seem to directly feed back into
the clock TTFL. However, the core clock circuitry is consolidated
by additional transcriptional circuits as well as post-translational
modiﬁcations that ensure high amplitude and a high-precision
clock.
3. Clock control of DNA repair
DNA repair is the ensemble of enzyme systems that eliminates
DNA damage which might be deﬁned as any covalent change in the
DNA structure [6]. There are several DNA repair mechanisms,
including direct repair (photolyases and alkyl transferases), base
excision repair (glycosylases and AP endonucleases), nucleotide
excision repair, and double-strand break/crosslink repair. Cur-
rently available evidence indicates that of these repair mecha-
nisms, only nucleotide excision repair is tightly controlled by the
circadian clock. Hence, the mechanism of nucleotide excision re-
pair and the control of this repair pathway by the circadian clock
will be discussed in some detail.
3.1. Nucleotide excision repair
Nucleotide excision repair (excision repair) is a universal repair
system that acts on virtually all types of base lesions. In many
organisms, including humans and mice, it is the only repair systemFig. 2. Mammalian molecular clock. The bHLH-PAS domain-containing proteins
Clock and BMal1 make a heterodimer which binds to the E-boxes (CACGTG) in the
promoters of the Per and Cry genes, as well as in the promoters of the clock-
controlled genes, such as the excision repair gene Xpa and the checkpoint gene
Wee1, activating their transcription. The Cry and Per proteins dimerize and, after a
time lag, enter the nucleus and inhibit Clock-BMal1-activated transcription of their
own genes as well as of those of clock-controlled genes, thus generating an
oscillatory pattern of gene expression. Modiﬁed from [67].for bulky DNA adducts such as ultraviolet (UV)-induced cyclobu-
tane pyrimidine dimers (Pyr<>Pyr) and cisplatin induced cis-
platin-1,2-d(GpG) diadducts. In humans, excision repair is carried
out by six factors [7–10]: RPA, XPA, XPC-HR23, TFIIH, XPG, and
XPF-ERCC1, and proceeds as follows (Fig. 3): RPA, XPA, and XPC,
acting cooperatively, bind to the damage site and recruit TFIIH
through its interactions with XPA and XPC. The two helicases with-
in the TFIIH complex (XPB and XPD) unwind the DNA by about
20 bp around the damage to form a stable complex called pre-inci-
sion complex 1 (PIC1). Then, XPG enters the assembly as XPC-HR23
exits, to form PIC2. Finally, XPF-ERCC1 is recruited through a strong
interaction with XPA to form PIC3. At each of these steps ATP is
hydrolyzed, and the free energy of ATP hydrolysis is used to un-
wind the helix as well as to amplify the damage recognition spec-
iﬁcity of the enzyme system by ‘‘kinetic proofreading” [9]. Within
PIC3, XPG makes the 30 incision 6 ± 3 phosphodiester bonds 30 to
the lesion and XPF makes the 50 incision 20 ± 5 phosphodiester
bonds 50 to the damage [10]. The resulting 24–32 nucleotide-long
oligomer carrying the lesion is released along with the repair fac-
tors, except RPA. The RPA-bound excision gap recruits RFC clamp
loader and PCNA clamp, and eventually DNA polymerases d/e
which ﬁll the excision gap, and the repair patch is ligated by
DNA ligase I.
Mutations in excision repair proteins XPA, XPB, XPC, XPD, XPF,
and XPG cause xeroderma pigmentosum. This disease is character-
ized by extreme sensitivity to sunlight, 10 000-fold increase in
the incidence of skin cancer, and, in some of the complementation
groups, by mental and developmental abnormalities [7,8]. In addi-
tion to the core excision repair factors essential for dual incision/
excision, an accessory protein, DDB2, which is encoded by the
XPE gene and is in a complex with a ubiquitin E3 ligase called
DDB1 (UV–DDB = DDB1–DDB2 = UV–damaged DNA binding pro-
tein), prevents UV carcinogenesis by an unknown mechanism
[11]. Finally, in a form of XP called XP variant (XPV), a mutationFig. 3. Model for nucleotide excision repair in humans and its regulation by the
circadian clock. Excision of DNA damage is accomplished by sequential and
partially overlapping functions of six core repair factors. Damage is recognized by
cooperative activities of RPA, XPA, and XPC, followed by recruitment of TFIIH by
XPC and XPA. The DNA around the damage site is unwound by the helicase activity
of TFIIH to form a stable pre-incision complex 1 (PIC1) which recruits XPG, and XPC
is displaced from the complex to form PIC2. Then XPF-ERCC1 is recruited to form
PIC3. Within PIC3, XPG makes the 30 incision 6 ± 3 phosphodiester bonds 30 and XPF
makes the 50 incision 20 ± 5 phosphodiester bonds 50 to the damage. The excised
24–32 nucleotide-long oligomer carrying the damage is released and the resulting
gap is ﬁlled by DNA polymerases and ligated. The XPA protein, which plays an
essential role in damage recognition and is a rate-limiting factor, is regulated by the
clock, and as a consequence the daily oscillation of XPA (sinusoidal arrow) causes
the entire excision repair activity to exhibit a daily rhythm, increasing during the
day and decreasing during the night. Modiﬁed from [9,66].
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prone translesion synthesis by other polymerases across UV-
photoproducts resulting in a high rate of mutation and cancer [12].
3.2. Regulation of nucleotide excision repair
Among the XP proteins, the regulation of XPE (DDB2), XPC-
HR23, and XPA have been studied in some detail. The XPE gene is
induced after DNA damage in a p53-dependent manner [13–15].
Then, the induced protein is ubiquitinated by the RING-type
CUL4a-Roc1-DDB1 E3 ligase and degraded by the proteasome
[16]. Similarly, XPC transcription is induced by DNA damage
including UV-induced damage [14,15]. However, in contrast to
DDB2, this transcriptional induction does not result in elevated
levels of XPC protein after DNA damage [17–19]. Like DDB2, XPC
is ubiquitinated by CUL4a-Roc1-DDB1 following DNA damage,
but unlike DDB2, ubiquitinated XPC is not targeted for proteolytic
degradation by the proteasome [17,18]. Currently, the physiologi-
cal relevance of DDB2 ubiquitination and degradation, and of XPC
ubiquitination, but not proteasomal degradation, are not known
[20–22]. In contrast, XPA is ubiquitinated independently of DNA
damage, and the ubiquitinated protein is targeted for proteolytic
degradation [23,24]. The regulation of mammalian excision repair
by XPA ubiquitination and proteolysis is discussed in more detail
below.
3.3. Regulation of nucleotide excision repair by the circadian clock
Analysis of nucleotide excision repair activity over the course of
a day in various mouse tissues revealed that the repair activity has
a robust circadian rhythm in brain [23] and liver but not in testis
[24] (Fig. 4A). Of the six core excision repair factors, only the XPA
protein oscillates, and this oscillation is in-phase with the excision
repair activity and anti-phase with the Cry1 protein which func-
tions as a transcriptional repressor in the core clock mechanism
[23]. Further analysis revealed that Xpa is a clock-controlled gene
that contains two canonical E-boxes in its promoter. Accordingly,
in Cry1/Cry2/ mice, Xpa transcription and XPA protein levels
are constitutively high and no longer rhythmic [24]. However, ro-
bust transcriptional rhythm is not necessarily sufﬁcient for rhyth-
mic protein levels. If the rhythmically transcribed protein is stable,
the transcriptional rhythm might confer protein level rhythmicity
of only modest amplitude. However, if the rhythmically tran-
scribed protein is targeted by the ubiquitin-proteasome system
for ubiquitination and subsequent degradation by proteolysis, then
high amplitude protein oscillation can be achieved. In fact, all core
clock proteins that exhibit rhythmicity, Cry1 and Cry2 [25,26], Per1Fig. 4. Circadian regulation of XPA and excision repair by the clock and the ubiquitin-pro
protein, and nucleotide excision repair in mouse liver (left panel) but not testis (right pa
HERC2 E3 ligase controls XPA stability. A549 cells were transfected with either cyclophili
protein synthesis inhibitor) for the indicated times and the XPA protein levels were detand Per2 [27,28], and BMal1 [29], are targeted by speciﬁc E3 ubiq-
uitin/SUMO ligases for ubiquitination or sumoylation and subse-
quent degradation by the proteasome. As a consequence, all of
these proteins have half-lives of 3 h. To ﬁnd out if proteolytic
degradation to achieve rhythmicity applied to a clock output pro-
tein, the half-life of XPA was measured and it was found that
XPA also has a half-life of 3 h [24].
Further analysis revealed that XPA is ubiquitinated by a HECT
family E3 ligase called HERC2 [24]. Downregulation of HERC2 sta-
bilizes XPA (Fig. 4B) and increases cellular repair capacity moder-
ately [24]. Similarly, in Cry1/Cry2/ cells, XPA levels and
excision repair activity are elevated. Interestingly, HERC2 itself is
a clock-controlled protein that oscillates in-phase with XPA in li-
ver, but it does not oscillate in the brain (T.H.K. and A.S., unpub-
lished data), even though Xpa transcription and XPA protein
levels oscillate in both organs. Thus, it appears that a protein such
as XPA that is made in a rhythmic manner may exhibit an oscilla-
tory pattern of accumulation whether it is degraded at a constant
rate or in an oscillatory manner.
In addition to XPA and excision repair, it has been reported that
O6-methylguanine-DNA methyl transferase [30] and alkylguanine
DNA glycosylase [31] also exhibit circadian oscillation. However,
the ratio of the zenith to the nadir for these enzymes is only about
1.2-fold (as opposed to 5- to 10-fold for XPA), and therefore the
physiological signiﬁcance of those oscillations is unclear at present.
4. Clock control of DNA damage checkpoints
DNA damage checkpoints are cellular surveillance mechanisms
that slow down or arrest cell cycle progression in response to DNA
damage [6]. In mammalian cells, two checkpoint signaling path-
ways have been described: the ATR? Chk1 pathway that is acti-
vated by UV, UV-mimetic agents, and chemical agents that
inhibit replication fork progression, and the ATM? Chk2 pathway
which is mainly activated by double-strand breaks that are in-
duced by ionizing radiation (IR) and radiomimetic agents (Fig. 5).
Both pathways encompass damage sensors, mediators, signal
transducers, and effectors. The damage is detected by the ATR
and ATM sensor kinases with the aid of accessory proteins, and is
transmitted to signal transducing kinases, Chk1 and Chk2, with
the aid of mediators. Signal transducing kinases then phosphory-
late effector proteins including p53, Cdc25, and Cdc45. Phosphory-
lation of these proteins eventually leads to inhibition of two key
kinases, Cdc2 and Cdk2, which cause cell cycle arrest at G2/M
and G1/S, respectively. In addition to halting cell cycle progression,
the DNA damage checkpoint response activates some DNA repair
pathways that rescue stalled replication forks and repair double-teasome system in the liver but not in testis. (A) Circadian rhythm of XPA transcript,
nel) (ZT = 0 is light on and ZT = 12 is light off; EST = Eastern Standard Time) [23]. (B)
n-B siRNA (control) or HERC2 siRNA and then incubated with cycloheximide (CHX, a
ermined by immunoblotting [24].
Fig. 5. DNA damage checkpoint pathways. The pathways encompass damage
sensors, mediators, signal transducers, and effectors. DNA damage in the form of
double-strand breaks induced by ionizing radiation or radiomimetic agents
activates the ATM? Chk2 pathway. DNA damage by UV and UV-mimetic agents
activates the ATR? Chk1 pathway. Modiﬁed from [6].
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point response in two ways: at the transcriptional level by control-
ling the transcription of the checkpoint proteins and by direct
participation of the clock proteins in the checkpoint response.
Accordingly, two mechanisms of circadian clock-DNA damage
checkpoint connection have been described, serial and direct con-
nections [32] (Fig. 6).Fig. 6. Two models for coupling the circadian clock to the cell cycle/checkpoint response.
the c-Myc transcription factor, which are involved in DNA repair, the cell cycle, and ce
hence DNA repair, checkpoint activation, cell cycle regulation, and cellular proliferation a
cycle by halting transcription during mitosis, thus causing a phase shift of the circadian
conjunction with Tim participates in the ATR-Chk1 signaling pathway in response to U
pathway in response to IR and radiomimetic agents.4.1. Serial connection of the circadian clock to the cell cycle
checkpoints
In this model of coupling of the clock to the cell cycle check-
points, the core clock system regulates genes that are involved in
generating checkpoint signals, in sensing these signals, and in
transducing the signals and executing the cell cycle arrest
(Fig. 6A). Examples for each of these are discussed below.
First, regulation of nucleotide excision repair by the clock
[23,24] results in generation of single-stranded DNA in the form
of excision gaps in a rhythmic manner. Single-stranded DNA is a
universal signal for ATR-mediated checkpoint signaling [6]. In
non-dividing cells exposed to UV or UV-mimetic agents such as
cisplatin, nucleotide excision repair is solely responsible for gener-
ating single-stranded DNA in the form of 24–32 nt-long excision
gaps. Although unprocessed damage itself and RNA polymerases
stalled at damage sites are capable of initiating checkpoint signal-
ing [6,33], it is most likely that in non-dividing cells at all times,
and even in proliferating cells in G1 and G2 phases of the cell cycle,
the excision gaps are the strongest signal for ATR activation. Be-
cause the XPA protein, and therefore excision repair activity, exhib-
its robust circadian rhythmicity, it is expected that UV-induced
checkpoint signaling in such cells would manifest similar rhyth-
micity. However, this deductive prediction awaits experimental
veriﬁcation.
Second, the c-myc oncogene, which plays a key role in cellular
proliferation as a bHLH transcription factor regulating a number
of genes critical for G1/S transition, is a ﬁrst-order clock-controlled
gene [34]. The mouse c-myc gene contains a canonical E-box in its
promoter to which BMal1-NPas2(Clock) bind and inhibit c-myc
transcription. In Per2 mutant mice, c-Myc is elevated because
Per2 positively regulates BMal1 transcription; and in the absence
of Per2, the BMal1–NPas2 level is reduced causing overexpression
of c-Myc and promotion of cellular proliferation. Indeed, it has
been reported that in Per2 mutant mice the overexpression of c-
Myc is a major contributor to high-incidence of IR-induced lym-
phomas [34].(A) Serial coupling. The XPA repair factor, the p21 and Wee1 cell cycle proteins, and
llular proliferation, respectively, are encoded by clock-controlled genes (CCG), and
re gated by the clock (solid line). Conversely, the cell cycle inﬂuences the circadian
rhythm (broken line). (B) Direct coupling. The core circadian clock protein Cry, in
V and UV-mimetic agents. Similarly, Per1 participates in the ATM-Chk2 signaling
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which is negatively regulated by Rev-Erba, which in turn is posi-
tively regulated by Clock-BMal1 [35]. Upon DNA damage, the tran-
scription of p21 is induced, and the elevated p21 protein level plays
a critical role in the maintenance of G1/S checkpoint by binding to
Cdk2 and inhibiting its activity. Furthermore, p21 binds to PCNA,
inhibits DNA replication, and thus participates in intra-S check-
point. Because of these important functions, it appears that in
BMal1mutant mice, reduced Rev-Erba activity and hence elevation
of p21 causes the mutant cells to exhibit a delay in the G1/S tran-
sition [35].
Finally, the Wee1 gene, which plays a key role in mitosis, is a
ﬁrst-order clock-controlled gene [36]. The Wee1 kinase phosphor-
ylates the mitotic cyclin-dependent kinase, Cdc2, causing its inac-
tivation and preventing the G2/M transition. In Cry mutant mice,
Wee1 is elevated in the liver, and as a consequence, after partial
hepatectomy, even though the wild-type and mutant hepatocytes
reportedly progress through the G1 and S phases of the cell cycle
similarly, the Cry mutants are delayed in entering mitosis, result-
ing in slower regeneration of the liver [36]. However, despite this
effect on normal hepatocyte progression through the cell cycle, it
appears that elevated Wee1 does not affect the G2/M checkpoint
signiﬁcantly: Cry1/Cry2/ mouse ﬁbroblasts, which overex-
press Wee1, exhibit growth properties and G2/M checkpoint re-
sponse to IR or UV indistinguishable from wild-type animals;
they do not have prolonged arrest at the G2/M boundary and re-
cover from the damage induced G2/M arrest essentially at the
same rate as wild-type cells [37]. It is thus likely that the conse-
quences of elevated Wee1 levels could be context-dependent and
modulated by cellular physiology, cell-type, and the cellular
environment.
4.2. Direct connection of the circadian clock to the DNA damage
checkpoints
In this mode of clock control of the checkpoint response, one or
more proteins in the core clock circuitry also participate in DNA
damage checkpoints. Currently, two examples for this mode of
coupling are known (Fig. 6B).
In one case, the Timeless (Tim) protein couples the clock to the
ATR? Chk1 signaling pathway [32]. Tim is an accessory clock
protein [1–3] that consolidates the core clock circuitry in mam-
malian organisms: Through its direct interaction with Cry it par-
ticipates in the molecular clock. Similarly, Tim participates in
ATR? Chk1 signaling through its direct interaction with both
ATR and Chk1 [32]. As a consequence, downregulation of Tim dis-
rupts both the circadian clock and the ATR? Chk1 DNA damage
signaling pathway. Downregulating Tim in SCN slices drastically
alters the levels of Crys and Pers and abolishes the oscillatory pat-
tern of the SCN electrochemical output, indicating that Tim is a
bona ﬁde clock protein in mammals [38]. However, Tim knockout
in mice causes embryonic lethality [1], and therefore, it has not
been possible to investigate the effect of Tim mutation on behav-
ioral rhythmicity because of its essential function. Essential
functions for Tim likely include its role in sister chromatid cohe-
sion and its role in both intra-S and replication checkpoints
[32].
In the second example of direct coupling of the clock to the DNA
damage checkpoints, Per1 participates both in the core clock
machinery and in the ATM? Chk2 DNA damage signaling path-
way [39]. The role of Per1 in the circadian clock as a co-repressor
is well-understood [1–3]. It participates in the negative arm of
the autoregulatory transcription-translation loop. Per1/ mice
have long periods and are prone to become arrhythmic in constant
darkness. In its role in the DNA damage checkpoints, Per1 partici-
pates in ATM? Chk2 signaling by directly interacting with bothATM and Chk2. Downregulation of Per1 interferes with phosphor-
ylation of Chk2 by ATM after IR treatment and reduces DNA dam-
age-induced apoptosis. Conversely, overexpression of Per1 inhibits
proliferation of a number of cancer cell lines by promoting apopto-
sis [39]. In agreement with the cell biological data, it has been re-
ported that Per1 is downregulated in a number of cancers,
including lung and breast cancers [39].5. Clock control of apoptosis
Apoptosis is programmed cell death that has important physio-
logic and pathologic consequences [40]. From a physiologic per-
spective, apoptosis plays an essential role during development in
sculpting organs during embryogenesis. From a pathologic stand-
point, it is an important contributor to cell death in several patho-
logic conditions such as tissue damage in cardiovascular and
cerebrovascular ischemia by initiating extensive cell death in re-
sponse to reactive oxygen species (ROS) generated by transient
ischemia [40]. Finally, one of the most signiﬁcant advances in can-
cer biology in recent years has been the realization of the impor-
tance of apoptosis in preventing oncogenically transformed cells
from proliferation and hence from producing overt cancer. It ap-
pears that, as a rule, oncogenically transformed cells are more
prone to apoptosis than normal cells [41].
Formally, two biochemical pathways of apoptosis have been de-
ﬁned [40], extrinsic and intrinsic pathways (Fig. 7A). In the mito-
chondria-independent, extrinsic (death receptor) pathway, a
member of the tumor necrosis factor family, such as TNFa, binds
to its cognate death receptor in the plasma membrane causing
clustering of the receptor and the cytoplasmic adaptor molecules,
and as a consequence, dimerization of pro-caspase 8. The latter is
activated by autoproteolysis in trans to generate initiator caspase
8, which in turn converts pro-caspase 3 to the executioner caspase
3 that dismantles cellular architecture, destroys some key cellular
enzymes, and activates caspase activated DNase (CAD) which at-
tacks chromosomes, generating the apoptosis signature feature,
the ‘‘nucleosome ladder” [42]. Recent work indicates that the core
circadian clock participates in the extrinsic pathway by regulating
the synthesis of TNFa [43]. Moreover, as TNFa is known to be in-
volved in the inﬂammatory response, Cry1/Cry2/ mice which
overexpress TNFa are uniquely sensitive to inﬂammatory stimuli
and exhibit a rheumatoid arthritis-like syndrome caused by such
stimuli [44].
In the intrinsic (or mitochondrial) pathway, cellular damage,
including DNA damage and stress caused by unfolded proteins,
leads to increased expression of pro-apoptotic members (Bax and
Bak) of the Bcl-2 family. The p53 tumor suppressor plays an impor-
tant role in DNA damage-initiated intrinsic apoptosis pathway
[41]. Indeed, it appears that p53 acts a tumor suppressor to a large
extent by inducing apoptosis in oncogenically transformed cells by
upregulating the expression of pro-apoptotic Bax and Bak in re-
sponse to genotoxic stress (Fig. 7A). With respect to clock-intrinsic
apoptosis pathway, there appears to be a direct connection be-
tween the core clock and p53: BMal1 upregulates [45] and Cry
downregulates [46] p53 expression, even though p53 does not
have a robust circadian rhythm because of multiple other inputs
into the regulation of this multipurpose tumor suppressor. In addi-
tion, in a cell-based assay, knockdown of p53 reduces the ampli-
tude of the circadian rhythm [47], but p53 mutant mice have an
apparently normal clock. Clearly, the clock-p53-apoptosis connec-
tion is rather complex. Of special signiﬁcance, p53/Cry1/Cry2/
 ﬁbroblasts are more sensitive to genotoxicant-induced apoptosis
than p53/ cells (Fig. 7B) [46], suggesting that Crys negatively reg-
ulate a p53-independent apoptotic pathway that becomes more
relevant in a p53/ background.
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The interfacing of the clock at multiple points with cellular re-
sponses to DNA damage leads to the inevitable prediction that cir-
cadian clock disruption may contribute to carcinogenesis and that
the clock would play signiﬁcant roles in cancers induced by geno-
toxicants as well as in treating cancers by DNA damaging agents.
Indeed, such connections do exist and these topics have been the
subject of several recent reviews [48–56] and will be discussed
here brieﬂy.
6.1. Circadian clock and cancer
Based largely on epidemiologic data, it was widely believed that
circadian clock disruption predisposes humans to cancer [48,49]. A
study with Per2 mutant mice seemed to support this view [34]. It
was reported that after IR treatment these mice developed lym-
phomas at about 10-fold higher incidence than wild-type mice.
The higher incidence of lymphoma was ascribed to upregulation
of c-myc oncogene and downregulation of p53 tumor suppressor,
and hence reduced apoptosis of transformed cells in the mutant
mice [34,48]. However, studies with Cry mutant mice revealed aFig. 7. Regulation of apoptosis by the circadian clock. (A) The extrinsic and intrinsic apo
the synthesis of TNFawhich binds to death receptors, which through death adaptors tran
caspase 3. In the intrinsic pathway, DNA damage activates p53 (in a circadian regulated m
family. Bax and Bak cause release of cytochrome c (c) from mitochondrial intermembra
cleavage and activation of transducer caspase 9 which in turn cleaves and activates execu
more sensitive to killing by apoptosis induced by genotoxic agents including UV [46]. (C)
analysis of mice of the indicated genotype is shown. Signiﬁcant differences were observmore complex pattern of interactions among the clock, apoptosis,
and oncogenic transformation. First, Cry1/Cry2/ mice, which
lack a circadian clock, are indistinguishable from wild-type mice
with respect to the incidence of both spontaneous and IR-induced
cancers [37]. Second, when the Cry mutation was combined with
the p53mutation, with the expectation that clock disruption would
increase cancer incidence in mice already predisposed to cancer
because of the p53 mutation, a paradoxical result was obtained
[46]: The Crymutation protected p53mutant mice from early onset
of cancer and extended their median lifespan by 50% from 19 to
28 weeks (Fig. 7C).
To explain this unexpected ﬁnding, immortal cell lines of p53/
and p53/Cry1/Cry2/ genotypes were analyzed for the integ-
rity of the DNA damage response pathways that contribute to can-
cer prevention, including DNA repair, DNA damage checkpoints,
and apoptosis. The two cell lines behaved similarly with respect
to repair of UV-induced DNA damage and UV-induced activation
of ATR? Chk1 and ATM? Chk2 signaling pathways [46]. In con-
trast, as noted above, it was found that elimination of Cry in
immortal p53-deﬁcient cells made the cells more sensitive to kill-
ing by apoptosis by genotoxic agents including UV (Fig. 7B). There-
fore, it was proposed that the increased sensitivity to apoptosis byptosis pathways. Circadian regulation of the extrinsic pathway occurs by regulating
sduce the signal to caspase 8 which in turn activates executioner caspases including
anner) which activates transcription of Bax and Bak pro-apoptotic members of Bcl-2
ne space. Cytochrome c helps assemble Apaf1 into an apoptosome which leads to
tioner caspase 3. (B) Elimination of Crys in immortal p53-deﬁcient cells makes cells
Cry mutations increase the lifespan of p53/ mice [46]. The Kaplan–Meier survival
ed between p53/ (n = 35) and p53/Cry1/Cry2/ (n = 19) mice (P < 0.0001).
2624 A. Sancar et al. / FEBS Letters 584 (2010) 2618–2625endo-toxicants might be the mechanism by which the Cry muta-
tion in p53mutant mice prevented oncogenically transformed cells
from proliferating to overt cancers. The mechanism by which the
Crymutation activates the p53-independent apoptosis pathway re-
mains to be elucidated.
Finally, studies with Clock or BMal1 mutant mice have rein-
forced the notion that clock disruption in itself does not predispose
animals to cancer. Thus, even though Clock mutants are more sen-
sitive than wild-type to acute lethal effects of cyclophosphamide,
presumably because of increased toxicity to B lymphocytes [57],
the mutants were indistinguishable from wild-type with respect
to the incidence of spontaneous and IR-induced cancers [58]. Sim-
ilarly, BMal1 mutants do not exhibit increased rates of cancers;
however, these mice exhibit a premature aging phenotype, pre-
sumably because of increased rate of ROS production [59] and
chronic oxidative stress.
To summarize, the hypothesis that clock disruption predisposes
animals to cancer, as a general rule, has not been supported by
experimental tests. A more conservative view that clock disruption
by certain mechanisms (such as Per mutations) or by unorthodox
lifestyles may promote cancer is plausible and it deserves further
critical investigations.
6.2. Circadian clock and chemotherapy
Chronochemotherapy is the administration of anticancer drugs
at speciﬁc times of the day so as to achieve optimal outcomes with
tolerable side effects [51–56]. The effect of genotoxic chemothera-
peutic drugs such as cisplatin on cancer cells is dictated, in addition
to pharmacokinetic and pharmacodynamic factors, by the cellular
response to DNA damage, including DNA repair, DNA damage
checkpoints, and apoptosis. Because these responses are, to varying
degrees, controlled by the clock, it is to be expected that the time of
drug delivery would affect its efﬁcacy. Indeed, some small scale
clinical trials have reported dramatic effects of chronochemother-
apy [51]. However, as a rule, the effects of chronotherapy in large
scale trials have been modest [56], and as a consequence chrono-
therapy is not currently practiced by oncologists. This is, in part,
due to the empirical nature of the past clinical trials. The recent ad-
vances in understanding the mechanistic links between the clock
and the DNA damage response summarized here are expected to
lead to mechanism-based chronotherapy regimens in the near fu-
ture. In fact, the high amplitude circadian oscillation of excision re-
pair has led to the proposal of the following speciﬁc cisplatin
chronotherapy schedule in a mouse model.
In all organs tested in mouse, with the exception of testis [24],
excision repair of cisplatin adducts is at its zenith at 5 pm and its
nadir at 5 am [24]. Therefore, a cisplatin treatment regimen that
would maximize cisplatin-DNA adduct formation at 5 am should
be most effective against mouse cancers responsive to cisplatin.
Moreover, it has been found that after intra-peritoneal injection
of a single cisplatin dose, the cisplatin-DNA adduct level reaches
its maximum in about 1 h in mouse liver and likely other major or-
gans except the brain [60]. Thus, ignoring other factors that might
inﬂuence the cytotoxicity of the drug, it would appear that 5 am
would be the best time to treat cancer with cisplatin in mice. Be-
cause circadian gene expression and circadian physiology of hu-
mans are out of phase with those of nocturnal mice by 12 h [52],
administering cisplatin at 5 pm might be optimal for treatment
of human cancers except testicular cancer. Indeed, there are re-
ports of higher success rate in treating ovarian cancer with cis-
platin when the drug is delivered at 6 pm compared to 6 am
[61,62]. However, these reports have not been supported by subse-
quent studies [52], underscoring the need for mechanism-based
approaches. Clearly, chemotherapeutic regimens that take into
consideration the circadian phases of both the cancer and the nor-mal tissue are needed to further reﬁne chronotherapy and make it
a standard part in the cancer treatment arsenal.7. Concluding remarks
According to the ‘‘Escape from Light” hypothesis for the evolu-
tion of the circadian clock [63], an ancient aquatic organism em-
ployed a blue light sensor (because blue light penetrates the
deepest in water) to synchronize its movements to and from the
surface of the ocean so as to optimize nutrient availability and
minimize exposure to the harmful effect of the UV component of
sunlight. It is conceivable that the last common ancestor of the
present day photolyase/Cry family was the blue light sensor direct-
ing the diel vertical movement as well as using the blue light as an
energy source to repair the UV-induced DNA damage that occurred
under those conditions [64,65]. This primitive ﬂavoprotein with
blue light absorption maxima then diverged to give rise to the
present day photolyases which repair DNA and to Crys that control
the circadian clock by light-dependent and light-independent
mechanisms [64,65].
Thus, even though the possible common evolutionary origin of
the circadian clock and the mechanisms to maintain genomic
integrity were recognized early-on in the circadian research ﬁeld
[63], only recently have the multiple links between the two sys-
tems been described. It should be noted, however, that even
though photolyase no longer has a photosensory function and
Cry no longer has a direct DNA repair function, Cry still participates
in the maintenance of genomic integrity against DNA damage in-
duced by UV and UV-mimetic agents [24,66]. Cry contributes to
DNA repair/genomemaintenance by regulating nucleotide excision
repair which is the sole repair mechanism for repairing UV-in-
duced photodimers in placental mammals which lack photolyase
[65], and by coordinating the circadian clock with DNA damage
checkpoints which also aids in cell survival and hence in ‘‘escape
from light” [63,65].References
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